Lifecore Biomedical, Inc
Price
FilingsNewest: 8-K, Material agreementSep 29 →InsidersNo open-market buys or sales.→Financing →PeersClosest companies: WOLF, HBIO, ASPN→
From the filings
Figures
- Operating cash flow
- −$206,000last 12 months
- Cash and equivalents
- $17.2Mat the last balance sheet
- Total debt
- $156.0Mat the last balance sheet
- Shares outstanding
- 37.7M shareson issue